Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
antiviral
Podcast
What 'The Next Berlin Patient' means for HIV drug development
This week on “The Top Line,” we dive into two studies in HIV research that were presented at the 25th International AIDS Conference in Germany.
Ayla Ellison
,
Angus Liu
Aug 2, 2024 9:43am
Merck's Lagevrio to be sold commercially in November, HHS says
Oct 5, 2023 10:35am
Shionogi drug to compete with Paxlovid and Lagevrio in Japan
Nov 22, 2022 11:18am
COVID-19 tracker: Pfizer, AstraZeneca, Moderna and more
Aug 31, 2022 11:15am
HHS earmarks $680M for smallpox drug, an Emergent buyout target
Aug 29, 2022 11:50am
Paxlovid sales are due to slip from 2023 on, GlobalData predicts
Jul 22, 2022 9:20am
